학술논문
1677P Pancreatic enzyme replacement therapy improves survival in patients receiving nab-paclitaxel plus gemcitabine as first-line treatment for advanced pancreatic adenocarcinoma
Document Type
Abstract
Author
Source
In Annals of Oncology October 2023 34 Supplement 2:S920-S920
Subject
Language
ISSN
0923-7534